KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Other Operating Expenses (2016 - 2025)

Gilead Sciences (GILD) has disclosed Other Operating Expenses for 17 consecutive years, with $2.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 63.42% year-over-year to $2.6 billion, compared with a TTM value of $7.8 billion through Dec 2025, down 48.0%, and an annual FY2025 reading of $7.8 billion, down 48.01% over the prior year.
  • Other Operating Expenses was $2.6 billion for Q4 2025 at Gilead Sciences, up from $1.7 billion in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $8.1 billion in Q1 2024 and bottomed at $1.2 billion in Q3 2021.
  • Average Other Operating Expenses over 5 years is $2.4 billion, with a median of $1.8 billion recorded in 2022.
  • The sharpest move saw Other Operating Expenses skyrocketed 331.31% in 2024, then plummeted 77.9% in 2025.
  • Year by year, Other Operating Expenses stood at $3.3 billion in 2021, then crashed by 52.85% to $1.6 billion in 2022, then surged by 60.04% to $2.5 billion in 2023, then crashed by 36.91% to $1.6 billion in 2024, then skyrocketed by 63.42% to $2.6 billion in 2025.
  • Business Quant data shows Other Operating Expenses for GILD at $2.6 billion in Q4 2025, $1.7 billion in Q3 2025, and $1.8 billion in Q2 2025.